Affy Sues Illumina in US and Europe Claiming Solexa Tech, BeadArray Infringes Its IP | GenomeWeb
NEW YORK (GenomeWeb News) — Affymetrix late yesterday said it has filed additional patent-infringement lawsuits against Illumina in the US, UK, and Germany claiming that the genome-analysis and array technologies Illumina acquired when it bought Solexa, as well as all of Illumina’s BeadArray products, infringe certain of its patents. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.